Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Pesqui. vet. bras ; 36(9): 874-880, set. 2016. tab, graf
Article in Portuguese | LILACS, VETINDEX | ID: biblio-829323

ABSTRACT

Esse estudo objetivou avaliar a composição química e potencial terapêutico do extrato hidroalcóolico de geoprópolis produzidas por abelhas Plebeia aff. flavocincta no semiárido do Rio Grande do Norte. Oito amostras (A-H) foram submetidas a quantificação dos teores de fenóis e flavonoides totais e avaliação da atividade antioxidante através do método DPPH (2,2-difenil-1-picril-hidrazilo). Além disso, foram investigadas as atividades antibacteriana, através do método de difusão em ágar, e a cicatrizante, através da indução de feridas cirúrgicas experimentais em Rattus norvegicus Berkenhout, 1769, linhagem Wistar, tratados com creme à base de geoprópolis. Duas amostras (F e G) se destacaram por apresentar altos valores de fenóis e flavonoides totais. A capacidade antioxidante acima de 90% foi observada em cinco amostras. Os extratos foram considerados eficazes no que se refere a atividade antibacteriana, pois das oito amostras, cinco promoveram a formação de halos de inibição ≥9mm para todas as cepas testadas. Duas amostras (D e G) se destacaram em relação as demais por apresentar excelentes resultados, uma vez que, promoveram a formação de halos de inibição para as bactérias Staphylococcus epidermidis e Escherichia coli, superiores estatisticamente aos valores dos antibióticos controles, quando na concentração de 100%. As amostras A e G promoveram, respectivamente, a formação de halos de inibição, que não diferiram significativamente dos halos produzidos pelos antibióticos controles em todas as concentrações testadas para E. coli e Staphylococcus aureus. A análise do processo de cicatrização sob os pontos de vista clínico, macroscópico e histológico permitiu concluir, que o uso do creme à base de geoprópolis apresentou influência positiva na cicatrização de feridas cutâneas experi­mentais, por promover reação inflamatória menos intensa e fechamento mais rápido das feridas em relação ao grupo controle.(AU)


This study aimed to evaluate the chemical composition and therapeutic potential of the hydroalcoholic extract of geopropolis produced by bees Plebeia aff. flavocincta in Rio Grande do Norte semi-arid. Eight samples (A-H) were submitted to the quantification of total phenols and flavonoid content and evaluation of the antioxidant activity by DPPH method (2,2-diphenyl-1-picryl-hydrazyl). Additionally, antibacterial activities were investigated by agar diffusion method, and healing process by inducing experimental surgical wounds in Rattus norvegicus Berkenhout, 1769, Wistar line, and treated with the geopropolis-based cream. Two samples (F and G) have stood out by presenting high values of total phenols and flavonoids. The antioxidant capacity of over 90% was observed in five samples. The extracts were considered effective in relation to antibacterial activity since of the eight samples, five promoted the formation of inhibition zones ≥9mm above all strains tested. Two samples (D and G) have stood out over the other for presenting excellent results since it promoted the formation of inhibition zones for Staphylococcus epidermidis and Escherichia coli exceeding statistically to the values of the antibiotic controls when the concentration was 100%. Samples A and G have provided, respectively, that the formation of inhibition zones were not significantly different than the halos produced by antibiotics controls at all concentrations tested for Escherichia coli and Staphylococcus aureus. The analysis of the healing process from the clinical, macroscopic and histological points of view, allowed to conclude that the use of geopropolis-based cream had a positive influence on the healing of experimental skin wounds by promoting less intense inflammatory reaction and healing faster from wounds in the control group.(AU)


Subject(s)
Animals , Rats , Anti-Bacterial Agents/analysis , Flavonoids/analysis , Phenols/analysis , Resins/analysis , Bees , Disk Diffusion Antimicrobial Tests , Hymenoptera , Pharmacological Phenomena , Rats, Wistar
2.
Rev. cuba. farm ; 42(3)sept.-dic. 2008. graf
Article in Spanish | LILACS | ID: lil-507005

ABSTRACT

Actualmente se han generado valiosísimas fuentes de información que correlacionan la especie botánica Cannabis sativa L y sus metabolitos secundarios con la medicina (tratamiento terapéutico), farmacología (modelos experimentales) y química sintética (diseño y generación de nuevas estructuras y análogos bioisósteres), que avalan la significación del estudio de esta planta, sus extractos, metabolitos, precursores y análogos naturales y sintéticos como fuente de agentes terapéuticos. Por tal motivo se presenta una revisión de la información existente sobre las potenciales implicaciones terapéuticas de sistemas moleculares canabinoidales (endógenos, naturales y sintéticos) en el tratamiento de diversas afecciones del sistema nervioso central, que incluye: conceptos de tipos de canabinoides; sistemas de receptores canabinoides CB1 y CB2 y sus ligandos así como evidencias preclínicas de los efectos terapéuticos de canabinoides desde 1970 hasta el 2006.


At present, a great amount of valuable information and experimental data has been generated that correlate Cannabis sativa and its secondary metabolites with medicine (therapeutic treatment), pharmacology (experimental animal models) and synthetic chemistry (design and generation of new structures and biososteric analogues), showing the importance of the study about this plant, its extracts, metabolite precursors and natural and synthetic analogues as therapeutic agents. Taking theses points into consideration, this article reviews the therapeutic implications of cannabinoid systems (endogenous, natural, and synthetic) on several pathologies of central nervous system, including: cannabinoid type concepts, cannabinoid receptor systems CB1 and CB2 and preclinical studies devoted to therapeutic effects of the cannabinoids since 1970 until 2006.


Subject(s)
Cannabinoids/therapeutic use , Ligands
SELECTION OF CITATIONS
SEARCH DETAIL